retatrutide clinical trial status ESC 2024: improves lipid and cardiovascular risk profile in Phase II TRIUMPH-3 🇦🇺 retatrutide cardiovascular/obesity clinical

Both telehealth companies are seeing 4x user growth and 60% revenue growth, fueling speculation for potential IPOs

The 21 cases involve GLP-1 users who suffered permanent vision loss after taking the medications

How are GLP-1 medications currently given in the UK

The glucagon arm drives basal energy expenditure upward a mechanism the dual-agonists do not have

As additional trials report, the picture of retatrutide efficacy and safety across different populations and indications will become increasingly complete

A common change that has a lot of people worried is how plans are handling GLP-1 medications diabetes and weight loss drugs you may know better by their common brand names, like Ozempic, Wegovy, Mounjaro, and Zepbound